EBRO 2017

Tra Pelvic irradiation in the randomized trials

Study

Stage

Design

C-C Field Size (cm)

N. Pts

FUP (years)

RFS (bioch or clin)

P-value

RTOG 77-06 T1b, T2 WPRT PORT

Upper border: L5-S1 NA

220

12

31 27

NS

225

RTOG 94-13 All T PSA <100 N+ risk >15%

WPRT PORT

16X16 11X11

410 410

7

36 36

NS

All T PSA <100 N+ risk >15%

WPRT PORT

16X16 11X11

322 323

7

40 27

0.023

RTOG 94-13 (sub-group analysis of patients receiving neoadjuvant HT)

T1b-T3, pNx

WPRT PORT

Upper border: S1-S2

225 221

5

66 65.3

NS

GETUG 01